{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:59:25Z","timestamp":1781715565627,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2024.126655","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T01:07:33Z","timestamp":1736298453000},"page":"126655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Long-term efficacy and anamnestic response of hepatitis B vaccine derived from Chinese hamster ovary cell after 18\u201320\u00a0years"],"prefix":"10.1016","volume":"47","author":[{"given":"Qiudong","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126655_bb0005","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1186\/s12889-022-13594-y","article-title":"Modelling the prevalence of hepatitis B towards eliminating it as a major public health threat in China","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2024.126655_bb0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2024.126655_bb0015","first-page":"33","article-title":"Hepatitis B virus: advances in prevention, diagnosis, and therapy","author":"Nguyen","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2024.126655_bb0020","first-page":"11","article-title":"Vertical transmission of hepatitis B virus-an update","author":"di Filippo","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.vaccine.2024.126655_bb0025","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1136\/gutjnl-2023-330691","article-title":"Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people","volume":"72","author":"Liu","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2024.126655_bb0030","article-title":"New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020","volume":"51","author":"Hui","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2024.126655_bb0035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2471\/BLT.18.219469","article-title":"Countdown to 2030: eliminating hepatitis B disease, China","volume":"97","author":"Liu","year":"2019","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2024.126655_bb0040","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126655_bb0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3201\/eid2305.161477","article-title":"Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China","volume":"23","author":"Cui","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126655_bb0050","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1016\/j.vaccine.2011.03.030","article-title":"Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese rural communities","volume":"29","author":"Zhang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126655_bb0055","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0264-410X(96)00239-3","article-title":"Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity","volume":"15","author":"Diminsky","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126655_bb0060","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.vaccine.2024.03.034","article-title":"CHO cells for virus-like particle and subunit vaccine manufacturing","volume":"42","author":"Sanchez-Martinez","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126655_bb0065","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.vaccine.2014.11.029","article-title":"The long-term efficacy of Chinese hamster ovary cell derived hepatitis B vaccine after being used for 14-16 years in Chinese rural communities","volume":"33","author":"Wang","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126655_bb0070","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1016\/j.vaccine.2011.06.045","article-title":"Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine","volume":"29","author":"Zhang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126655_bb0075","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/21645515.2018.1509172","article-title":"Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis","volume":"15","author":"Wu","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126655_bb0080","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1016\/j.vaccine.2012.08.067","article-title":"Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in China","volume":"30","author":"Shen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126655_bb0085","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1186\/s12879-024-09716-z","article-title":"The spatial-temporal distribution of hepatitis B virus infection in China, 2006\u20132018","volume":"24","author":"Jiao","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126655_bb0090","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.vaccine.2012.01.052","article-title":"Long-term efficacy of 10-12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese rural communities","volume":"30","author":"Wang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126655_bb0095","article-title":"Booster dose vaccination for preventing hepatitis B","volume":"2016","author":"Poorolajal","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2024.126655_bb0100","first-page":"E184","article-title":"Long-term persistency of hepatitis B immunity: an observational cross-sectional study on medical students and resident doctors","volume":"60","author":"Stefanati","year":"2019","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.vaccine.2024.126655_bb0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/cid\/cir270","article-title":"Hepatitis B and the need for a booster dose","volume":"53","author":"Leuridan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126655_bb0110","first-page":"357","article-title":"HBV vaccination and HBV infection induces HBV-specific natural killer cell memory","volume":"70","author":"Wijaya","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2024.126655_bb0115","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1080\/21645515.2020.1852869","article-title":"Long-term immune protection against HBV: associated factors and determinants","volume":"17","author":"Mastrodomenico","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126655_bb0120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijid.2018.08.024","article-title":"Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China","volume":"78","author":"Wang","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126655_bb0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/21645515.2017.1264788","article-title":"Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: a cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy","volume":"13","author":"Dini","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126655_bb0130","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s41423-022-00939-1","article-title":"Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction","volume":"19","author":"Zhao","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2024.126655_bb0135","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.vaccine.2016.12.062","article-title":"Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults","volume":"35","author":"Wang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126655_bb0140","doi-asserted-by":"crossref","first-page":"785","DOI":"10.11150\/kansenshogakuzasshi1970.67.785","article-title":"Immunogenicity of Chinese hamster ovary cell derived HB vaccine--a comparative study with yeast derived HB vaccine","volume":"67","author":"Kashiwagi","year":"1993","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.vaccine.2024.126655_bb0145","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4161\/hv.7.10.15990","article-title":"The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination","volume":"7","author":"Yao","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2024.126655_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202000266","article-title":"The degree and length of O-glycosylation of recombinant proteins produced in Pichia pastoris depends on the nature of the protein and the process type","volume":"16","author":"Radoman","year":"2021","journal-title":"Biotechnol J"},{"key":"10.1016\/j.vaccine.2024.126655_bb0155","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T22:24:49Z","timestamp":1740349489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24013379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":31,"alternative-id":["S0264410X24013379"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126655","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term efficacy and anamnestic response of hepatitis B vaccine derived from Chinese hamster ovary cell after 18\u201320\u00a0years","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126655"}}